跳至主要内容
临床试验/NL-OMON50126
NL-OMON50126已完成不适用

The role of dopamine and oxytocin in individual and social performance monitoring - Dopamine, oxytocin and performance monitoring

niversiteit Leiden0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Healthy, right-handed males between age 18 and 35 with no history of
  • neurological disorder/disease, no substantial psychiatric history, and no
  • counter-indications to MRI will be included in this study.

排除标准

  • Participants should meet none of the following exclusion criteria:
  • - History of medication or drugs within 1 month prior to the start of treatment
  • with trial medication with the exception of occasional use of paracetamol.
  • - Previous experience of allergic reaction upon administration of a drug.
  • - Use of hayfever medication
  • - Medical or surgical history that in the investigator*s view may significantly
  • affect the outcome of the trial; such as severe visual impairment
  • - Significant history of head trauma, premature birth, or learning disabilities.
  • - Heart arrhythmia (including pacemaker/ICD), glaucoma, hypertension.
  • - Clinically significant history of abnormal cardiovascular, endocrine,
  • psychiatric, neurological or hematological disease.
  • - Febrile illness within 3 days before the first dose
  • - Fever or cold within 2 days before the experiment
  • - Participation in another drug study within 3 months preceding participation
  • in the current study.
  • - Intake of more than 3 units of alcohol / day
  • - Smoking more than 5 cigarettes / day
  • - Inability to understand the nature and extent of the trial and the procedures

研究者

发起方
niversiteit Leiden

相似试验